Skip to content

Author

Bin Zou

We have 3 of 9 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

KRAS inhibition drives adaptive surfaceome remodeling and reveals ALPP/ALPPL2 as a targetable vulnerability in pancreatic cancer

Together, these studies comprehensively define the KRASi-induced proteome and identify ALPP/ALPPL2 as a promising cell surface target for combination with KRASi to enhance response and forestall KRASi resistance.

Jonathan M. DeLiberty, Fan-Yi Kong, Qi-Jia Yu et al. · 0 citations
Open access Oct 2026

Proximity-Induced Disulfide Rebridging Enables Modular Construction of Stable Antibody-Drug Conjugates.

A kinetically differentiated rebridging strategy using a class of heterotrifunctional rebridging reagents, 5-fluoro-4-(phenylsulfonyl)pyridine derivatives, which can efficiently rebridge reduced disulfide bonds in antibodies to construct diverse types of antibody conjugates under physiological conditions is reported.

Bin-Bin Pan, Xiao-Hui Zhou, Xing Zhang et al. · 0 citations
Sep 2026

Abstract A041: KRAS inhibition drives adaptive surfaceome remodeling and reveals ALPP/ALPPL2 as a targetable vulnerability in pancreatic cancer

These studies establish a comprehensive proteomic resource for the PDAC/KRASi research community and identify ALPP/ALPPL2 as a promising cell surface target for combination with KRASi to drive deeper, sustained responses and prevent or forestall KRASi resistance.

Jonathan M. DeLiberty, Fan-Yi Kong, Qi-Jia Yu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.